Table 1. Neoadjuvant chemotherapy dataset used for analyses.
| Dataset (Trial) | Total patient # (with response) | TNBC patient # (with response) | TNBC (%) | Neoadjuvant Chemotherapy | Reference |
|---|---|---|---|---|---|
| GSE25066 (MDACC) | 508 (488) | 182 (176) | 35.8 | AT | Hatzis et al. |
| GSE22358 (XeNA) | 154 (122) | 62 (46) | 40.3 | Capecitabine + D | Glück et al. |
| GSE22226 (I-SPY-1) | 149 (144) | 34 (34) | 22.8 | AT | Essermann et al. |
| GSE32646 (Osaka) | 115 (115) | 31(31) | 27.0 | T + 5-FU/E/C | Miyake et al. |
| GSE41998 (BMS) | 279 (273) | 144 (130) | 51.6 | AC + 1:1 IXA or T | Horak et al. |
5-FU, 5-fluorouracil; A, anthracycline; C, cyclophosphamide; D, docetaxel; E, epirubicin; IXA, ixabepilone; and T, taxane.